Literature DB >> 35103148

Hyperferritinemia and the Extent of Mucormycosis in COVID-19 Patients.

Simple Bhadania1, Neena Bhalodiya1, Yashendra Sethi2, Nirja Kaka3, Swati Mishra1, Neil Patel3, Asad Ullah Wasim4, Saumya S Joshi5, Kenisha Shah5.   

Abstract

Introduction Coronavirus disease 2019 (COVID-19) disease attributed to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has shown associations with various fungal opportunistic infections such as mucormycosis, invasive candidiasis, and aspergillosis, which have contributed to the mortality of the disease. In India, the incidence of mucormycosis had risen rapidly during the second wave. There is ample literature demonstrating the role of iron in the pathogenesis of mucormycosis. The hyperferritinemia associated with COVID-19 may have played a significant role in promoting the invasion and extent of the fungus. Aims and objectives The study aimed to analyze the association between serum ferritin levels and the extent of involvement of mucormycosis in patients affected with COVID-19. Methodology A single-center cross-sectional study was conducted using retrospective hospital record data. G*Power statistical analysis software was used to compute the sample size of 62 (31+31). The radiological data were used to determine the extent of involvement. Results A statistically significant difference was seen in levels of serum ferritin (p = 0.008) between the radiologically judged two groups of the mild extent of invasion of mucormycosis (rhinosinusitis) and severe extent of invasion (rhino-orbital/cerebral mucormycosis), with a severe extent seen with the group having higher levels of serum ferritin. Severe extent of invasion was seen in 53.6% of patients with diabetes mellitus and 62.5% of patients with both diabetes and hypertension. Conclusion The hyperferritinemia not only presents as a marker of the systemic inflammatory process in COVID-19 but also indicates increased free iron, which thereby aids the growth and extent of involvement by the fungus (R hizopus oryzae). In individuals with diabetes and hypertension, the severity was greater. Controlling catastrophic outcomes in individuals with high serum ferritin levels necessitates extra caution.
Copyright © 2021, Bhadania et al.

Entities:  

Keywords:  covid-19; extent of mucormycosis; ferritin; hyperferritinemia; mucormycosis

Year:  2021        PMID: 35103148      PMCID: PMC8772619          DOI: 10.7759/cureus.20569

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  28 in total

Review 1.  Pathogenesis of mucormycosis.

Authors:  Ashraf S Ibrahim; Brad Spellberg; Thomas J Walsh; Dimitrios P Kontoyiannis
Journal:  Clin Infect Dis       Date:  2012-02       Impact factor: 9.079

Review 2.  Diabetes mellitus and its complications in India.

Authors:  Ranjit Unnikrishnan; Ranjit Mohan Anjana; Viswanathan Mohan
Journal:  Nat Rev Endocrinol       Date:  2016-04-15       Impact factor: 43.330

Review 3.  The ecology of the Zygomycetes and its impact on environmental exposure.

Authors:  M Richardson
Journal:  Clin Microbiol Infect       Date:  2009-10       Impact factor: 8.067

Review 4.  Iron acquisition: a novel perspective on mucormycosis pathogenesis and treatment.

Authors:  Ashraf S Ibrahim; Brad Spellberg; John Edwards
Journal:  Curr Opin Infect Dis       Date:  2008-12       Impact factor: 4.915

5.  Sino-orbital mucormycosis in a COVID-19 patient: A case report.

Authors:  Aastha Maini; Gaurav Tomar; Deepak Khanna; Yogesh Kini; Hardik Mehta; V Bhagyasree
Journal:  Int J Surg Case Rep       Date:  2021-05-04

Review 6.  Global Epidemiology of Mucormycosis.

Authors:  Hariprasath Prakash; Arunaloke Chakrabarti
Journal:  J Fungi (Basel)       Date:  2019-03-21

Review 7.  Therapeutic role of corticosteroids in COVID-19: a systematic review of registered clinical trials.

Authors:  Reshma Raju; Prajith V; Pratheeksha Sojan Biatris; Sam Johnson Udaya Chander J
Journal:  Futur J Pharm Sci       Date:  2021-03-17

8.  Mucormycosis with orbital compartment syndrome in a patient with COVID-19.

Authors:  Amanda Werthman-Ehrenreich
Journal:  Am J Emerg Med       Date:  2020-09-16       Impact factor: 4.093

Review 9.  Fungal Co-infections Associated with Global COVID-19 Pandemic: A Clinical and Diagnostic Perspective from China.

Authors:  Ge Song; Guanzhao Liang; Weida Liu
Journal:  Mycopathologia       Date:  2020-07-31       Impact factor: 3.785

View more
  3 in total

Review 1.  Deferiprone: A Forty-Year-Old Multi-Targeting Drug with Possible Activity against COVID-19 and Diseases of Similar Symptomatology.

Authors:  George J Kontoghiorghes
Journal:  Int J Mol Sci       Date:  2022-06-16       Impact factor: 6.208

2.  Estimation of Serum Ferritin in Mucormycosis Patients and Prognostication Based on the Ferritin Value.

Authors:  Babu Anand C; Sivasubramaniyam Senthilkumar; Nivedha P; Mohammed Ibrahim C; Khizer Hussain Afroze M; Ramanathan M
Journal:  Cureus       Date:  2022-04-10

Review 3.  COVID-19-Associated Mucormycosis: A Matter of Concern Amid the SARS-CoV-2 Pandemic.

Authors:  Pankaj Chandley; Priyanka Subba; Soma Rohatgi
Journal:  Vaccines (Basel)       Date:  2022-08-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.